Douglas Richard

Insider Reports History

Entity
Company
Location
One Kendall Square, Cambridge, MA
Signature
/s/Mark J. Casey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas Richard:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NOVAVAX INC Director Common Stock 43.9K $610K $13.90 Jun 12, 2024 Direct
MAXCYTE, INC. Director Common Stock 121K $595K $4.90 Jun 11, 2024 Direct
NOVAVAX INC Director Stock Option (Right to Buy) 15.6K $248K $15.86 Jun 12, 2024 Direct
NOVAVAX INC Director Restricted Stock Units 10.4K $145K $13.90 Jun 12, 2024 Direct
MAXCYTE, INC. Director Stock Option (right to buy) 40.7K Jun 11, 2024 Direct
Aldeyra Therapeutics, Inc. Director Stock Option (Right to Buy) 1.22K Jun 4, 2024 Direct

Insider Reports Filed by Douglas Richard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NVAX NOVAVAX INC Jun 12, 2024 4 $248K 4 Jun 14, 2024 Director
MXCT MAXCYTE, INC. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director
ALDX Aldeyra Therapeutics, Inc. Jun 4, 2024 3 $0 4 Jun 6, 2024 Director
ALDX Aldeyra Therapeutics, Inc. Jun 30, 2023 3 $0 4 Jul 5, 2023 Director
MXCT MAXCYTE, INC. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
NVAX NOVAVAX INC Jun 10, 2023 4 $0 4 Jun 13, 2023 Director
MXCT MAXCYTE, INC. Mar 29, 2023 1 $345K 4 Mar 30, 2023 Director
MXCT MAXCYTE, INC. Jun 29, 2022 1 $0 4 Jul 8, 2022 Director
NVAX NOVAVAX INC Jun 17, 2022 2 $0 4 Jun 21, 2022 Director
NVAX NOVAVAX INC Jun 10, 2022 2 $0 4 Jun 14, 2022 Director
ALDX Aldeyra Therapeutics, Inc. Jun 7, 2022 3 $0 4 Jun 9, 2022 Director
NVAX NOVAVAX INC Dec 13, 2021 2 $38.4K 4 Dec 15, 2021 Director
MXCT MAXCYTE, INC. Nov 22, 2021 1 $222K 4 Nov 23, 2021 Director
MXCT MAXCYTE, INC. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
MXCT MAXCYTE, INC. Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
NVAX NOVAVAX INC Jun 25, 2021 2 $0 4 Jun 29, 2021 Director
NVAX NOVAVAX INC Jun 17, 2021 2 $0 4 Jun 22, 2021 Director
ALDX Aldeyra Therapeutics, Inc. Jun 8, 2021 3 $0 4 Jun 10, 2021 Director